The U.S. chemicals sector presents investors with a diverse landscape, and two notable mid-cap names — CBT (Cabot Corporation) and OLN (Olin Corporation) — offer contrasting exposures within this space. Both are well-established industrial firms, yet their business models, end markets, and recent stock trajectories diverge meaningfully. For traders and investors seeking to understand relative performance, momentum dynamics, and where AI-driven analytics see opportunity, this head-to-head comparison examines each company's fundamentals, recent developments, and market positioning. Understanding the distinctions between these two stocks can help market participants make more informed decisions in a complex macroeconomic environment.
Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company operates through two primary segments: Reinforcement Materials, which produces carbon black used in tires and industrial rubber products, and Performance Chemicals, which includes fumed silica and specialty compounds used in adhesives, coatings, and battery applications. In recent weeks, CBT has drawn market attention for its expanding role in the electric vehicle supply chain, particularly through conductive carbon additives that enhance lithium-ion battery performance. This secular growth tailwind has contributed to a more resilient share price compared to broader commodity-exposed chemical peers. Recent quarterly results reflected stable demand in specialty applications, and management commentary has emphasized disciplined capital allocation alongside strategic investments in higher-margin, innovation-driven product lines. Institutional interest has remained steady, with the stock maintaining a constructive technical posture through recent market activity.
Olin Corporation, based in Clayton, Missouri, is a vertically integrated chemical manufacturing and ammunition production company. Its core operations span three segments: Chlor Alkali Products and Vinyls, Epoxy, and Winchester ammunition. The Chlor Alkali business is highly sensitive to industrial economic cycles, as it produces chlorine, caustic soda, and related derivatives used across construction, automotive, and water treatment industries. In recent market activity, OLN has faced headwinds tied to weaker chlor-alkali pricing, elevated energy costs in its production processes, and sluggish demand in the global epoxy market. While the Winchester segment has provided a degree of earnings stability, it has not fully offset compression in chemical margins. The company has pursued cost-reduction measures and operational efficiency initiatives, but broader macroeconomic uncertainty and industrial demand softness have weighed on sentiment. The stock's recent price action reflects these challenges, with volatility remaining a defining characteristic.
In a market environment where sector rotations and macro-driven swings can challenge even seasoned traders, AI-powered tools are gaining traction as decision-support resources. Tickeron's Trending AI Robots page curates a selection of top-performing AI trading bots from a universe of hundreds that actively trade thousands of different tickers. Each bot employs distinct trading styles, strategies, timeframes, and risk parameters, with performance statistics — including win rates, trade frequency, and drawdown metrics — available for user review. The robots featured on this page are those demonstrating the strongest real-time alignment with prevailing market conditions, making the section a dynamic showcase of adaptability and model strength. For traders interested in data-driven market engagement, exploring the Trending AI Robots page offers a practical starting point for understanding AI-assisted trading.
When comparing CBT and OLN, several structural differences stand out. Cabot's business leans toward specialty and performance-oriented chemicals, which typically carry higher barriers to entry and more stable pricing power than the commodity-linked products that define much of Olin's portfolio. CBT's exposure to secular themes — particularly the electrification of transportation — provides a growth narrative that OLN lacks in its chemical operations. Conversely, OLN's Winchester division offers a unique, counter-cyclical attribute not present in CBT, though it constitutes a smaller share of total earnings.
From a risk perspective, OLN carries greater sensitivity to macroeconomic indicators such as industrial production, housing starts, and energy input costs, given the commodity nature of chlor-alkali and epoxy products. CBT, while not immune to economic cycles, benefits from a more diversified customer base and product mix. On valuation, both stocks trade in a broadly similar mid-cap value range, but CBT has commanded a relative premium in recent weeks, reflecting its stronger earnings visibility. Sector exposure also differs: CBT aligns more closely with durable goods and automotive trends, whereas OLN's performance correlates more directly with heavy industrial activity and construction cycles.
Based on an assessment of observable trend consistency, relative momentum, and sector-level positioning, Tickeron's AI analytics would likely favor CBT over OLN in the current market environment. CBT's steadier technical profile, its exposure to secular growth drivers in energy storage and specialty applications, and its comparatively more resilient earnings trajectory provide a foundation that AI models tend to identify as probabilistically more favorable. OLN's cyclical headwinds, while potentially setting up a longer-term recovery opportunity, introduce a level of uncertainty that statistical models often weigh cautiously. This assessment reflects a probabilistic, data-driven reading of current conditions and is not a prediction of future outcomes; market dynamics can shift, and each investor's objectives and risk tolerance differ materially.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CBT’s FA Score shows that 2 FA rating(s) are green whileOLN’s FA Score has 2 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CBT’s TA Score shows that 4 TA indicator(s) are bullish while OLN’s TA Score has 5 bullish TA indicator(s).
CBT (@Chemicals: Specialty) experienced а -2.36% price change this week, while OLN (@Chemicals: Major Diversified) price change was -20.22% for the same time period.
The average weekly price growth across all stocks in the @Chemicals: Specialty industry was -0.32%. For the same industry, the average monthly price growth was -2.98%, and the average quarterly price growth was +7.69%.
The average weekly price growth across all stocks in the @Chemicals: Major Diversified industry was -4.43%. For the same industry, the average monthly price growth was -1.41%, and the average quarterly price growth was -2.52%.
CBT is expected to report earnings on Aug 03, 2026.
OLN is expected to report earnings on Oct 22, 2026.
The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.
@Chemicals: Major Diversified (-4.43% weekly)The major diversified chemicals industry includes companies that produce a wide range of chemicals and industrial gases. The products are often used as raw materials in the manufacturing of various types of goods, including plastics, paints, carpets, and fixtures to name a few. Major companies making diversified chemicals include DuPont de Nemours Inc., Celanese Corporation, Celanese Corporation and Westlake Chemical Corporation.
| CBT | OLN | CBT / OLN | |
| Capitalization | 4.54B | 2.11B | 215% |
| EBITDA | 752M | 410M | 183% |
| Gain YTD | 34.317 | -9.797 | -350% |
| P/E Ratio | 16.61 | 48.57 | 34% |
| Revenue | 3.58B | 6.7B | 53% |
| Total Cash | 252M | 177M | 142% |
| Total Debt | 1.3B | 3.41B | 38% |
CBT | OLN | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 58 | 16 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 30 Undervalued | 11 Undervalued | |
PROFIT vs RISK RATING 1..100 | 62 | 100 | |
SMR RATING 1..100 | 48 | 95 | |
PRICE GROWTH RATING 1..100 | 43 | 63 | |
P/E GROWTH RATING 1..100 | 12 | 10 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
OLN's Valuation (11) in the Industrial Specialties industry is in the same range as CBT (30). This means that OLN’s stock grew similarly to CBT’s over the last 12 months.
CBT's Profit vs Risk Rating (62) in the Industrial Specialties industry is somewhat better than the same rating for OLN (100). This means that CBT’s stock grew somewhat faster than OLN’s over the last 12 months.
CBT's SMR Rating (48) in the Industrial Specialties industry is somewhat better than the same rating for OLN (95). This means that CBT’s stock grew somewhat faster than OLN’s over the last 12 months.
CBT's Price Growth Rating (43) in the Industrial Specialties industry is in the same range as OLN (63). This means that CBT’s stock grew similarly to OLN’s over the last 12 months.
OLN's P/E Growth Rating (10) in the Industrial Specialties industry is in the same range as CBT (12). This means that OLN’s stock grew similarly to CBT’s over the last 12 months.
| CBT | OLN | |
|---|---|---|
| RSI ODDS (%) | N/A | 4 days ago 71% |
| Stochastic ODDS (%) | 4 days ago 70% | 4 days ago 73% |
| Momentum ODDS (%) | 4 days ago 68% | 4 days ago 77% |
| MACD ODDS (%) | 4 days ago 60% | 4 days ago 78% |
| TrendWeek ODDS (%) | 4 days ago 65% | 4 days ago 74% |
| TrendMonth ODDS (%) | 4 days ago 65% | 4 days ago 73% |
| Advances ODDS (%) | 6 days ago 68% | 13 days ago 68% |
| Declines ODDS (%) | 4 days ago 66% | 4 days ago 73% |
| BollingerBands ODDS (%) | 4 days ago 65% | 4 days ago 67% |
| Aroon ODDS (%) | 4 days ago 65% | 4 days ago 58% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| EMDM | 39.90 | 0.18 | +0.46% |
| First Trust Bloomberg Emr Mkt Dem ETF | |||
| CPNJ | 27.45 | 0.03 | +0.09% |
| Calamos Nasdaq-100 Str Alt Prt ETF-Jun | |||
| GXLC | 90.16 | N/A | N/A |
| Global X U.S. 500 ETF | |||
| RPV | 118.94 | -0.43 | -0.36% |
| Invesco S&P 500® Pure Value ETF | |||
| PBE | 89.61 | -1.49 | -1.64% |
| Invesco Biotechnology & Genome ETF | |||
A.I.dvisor indicates that over the last year, CBT has been closely correlated with IOSP. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if CBT jumps, then IOSP could also see price increases.
| Ticker / NAME | Correlation To CBT | 1D Price Change % | ||
|---|---|---|---|---|
| CBT | 100% | -0.24% | ||
| IOSP - CBT | 67% Closely correlated | -0.10% | ||
| ASIX - CBT | 62% Loosely correlated | -2.62% | ||
| OLN - CBT | 61% Loosely correlated | -16.51% | ||
| AVNT - CBT | 60% Loosely correlated | -0.98% | ||
| FUL - CBT | 57% Loosely correlated | -0.14% | ||
More | ||||
A.I.dvisor indicates that over the last year, OLN has been closely correlated with DOW. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if OLN jumps, then DOW could also see price increases.